Synovus Financial’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.93M | Buy |
19,621
+1,430
| +8% | +$142K | 0.02% | 376 |
|
|
2025
Q2 | $1.66M | Sell |
18,191
-1,916
| -10% | -$185K | 0.02% | 384 |
|
|
2025
Q1 | $2.28M | Buy |
20,107
+409
| +2% | +$43.8K | 0.03% | 328 |
|
|
2024
Q4 | $2.08M | Sell |
19,698
-586
| -3% | -$62.9K | 0.03% | 347 |
|
|
2024
Q3 | $2.19M | Sell |
20,284
-1,620
| -7% | -$177K | 0.03% | 358 |
|
|
2024
Q2 | $2.38M | Buy |
21,904
+493
| +2% | +$58.1K | 0.03% | 314 |
|
|
2024
Q1 | $2.83M | Sell |
21,411
-623
| -3% | -$77.8K | 0.04% | 282 |
|
|
2023
Q4 | $2.68M | Sell |
22,034
-43,046
| -66% | -$4.8M | 0.04% | 282 |
|
|
2023
Q3 | $7.3M | Buy |
65,080
+20,449
| +46% | +$2.6M | 0.08% | 145 |
|
|
2023
Q2 | $6.5M | Buy |
44,631
+26,229
| +143% | +$3.56M | 0.07% | 158 |
|
|
2023
Q1 | $2.38M | Sell |
18,402
-876
| -5% | -$110K | 0.03% | 309 |
|
|
2022
Q4 | $2.46M | Sell |
19,278
-289
| -1% | -$33.5K | 0.03% | 306 |
|
|
2022
Q3 | $2.04M | Buy |
19,567
+1,486
| +8% | +$163K | 0.03% | 310 |
|
|
2022
Q2 | $1.91M | Buy |
18,081
+2,185
| +14% | +$259K | 0.02% | 328 |
|
|
2022
Q1 | $2.04M | Buy |
15,896
+2,122
| +15% | +$256K | 0.02% | 326 |
|
|
2021
Q4 | $1.71M | Buy |
13,774
+1,389
| +11% | +$182K | 0.02% | 352 |
|
|
2021
Q3 | $1.76M | Buy |
12,385
+10,545
| +573% | +$1.55M | 0.02% | 334 |
|
|
2021
Q2 | $287K | Buy |
1,840
+103
| +6% | +$16.7K | ﹤0.01% | 731 |
|
|
2021
Q1 | $271K | Hold |
1,737
| – | – | ﹤0.01% | 671 |
|
|
2020
Q4 | $259K | Buy |
1,737
+67
| +4% | +$9.46K | ﹤0.01% | 678 |
|
|
2020
Q3 | $221K | Hold |
1,670
| – | – | ﹤0.01% | 662 |
|
|
2020
Q2 | $193K | Sell |
1,670
-1,133
| -40% | -$131K | ﹤0.01% | 659 |
|
|
2020
Q1 | $275K | Buy |
2,803
+814
| +41% | +$107K | ﹤0.01% | 696 |
|
|
2019
Q4 | $289K | Hold |
1,989
| – | – | ﹤0.01% | 603 |
|
|
2019
Q3 | $266K | Hold |
1,989
| – | – | ﹤0.01% | 594 |
|
|
2019
Q2 | $226K | Buy |
1,989
+319
| +19% | +$37.4K | ﹤0.01% | 583 |
|
|
2019
Q1 | $208K | Sell |
1,670
-356
| -18% | -$40.5K | ﹤0.01% | 575 |
|
|
2018
Q4 | $202K | Sell |
2,026
-26
| -1% | -$2.92K | ﹤0.01% | 563 |
|
|
2018
Q3 | $263K | Sell |
2,052
-110
| -5% | -$13.1K | ﹤0.01% | 549 |
|
|
2018
Q2 | $232K | Sell |
2,162
-206
| -9% | -$22.4K | ﹤0.01% | 557 |
|
|
2018
Q1 | $252K | Sell |
2,368
-428
| -15% | -$49.7K | ﹤0.01% | 533 |
|
|
2017
Q4 | $324K | Sell |
2,796
-75
| -3% | -$8.48K | 0.01% | 484 |
|
|
2017
Q3 | $329K | Buy |
2,871
+514
| +22% | +$59.3K | 0.01% | 466 |
|
|
2017
Q2 | $293K | Buy |
2,357
+139
| +6% | +$16.5K | 0.01% | 500 |
|
|
2017
Q1 | $262K | Buy |
2,218
+227
| +11% | +$25.7K | 0.01% | 479 |
|
|
2016
Q4 | $200K | Buy |
1,991
+7
| +0.4% | +$750 | ﹤0.01% | 501 |
|
|
2016
Q3 | $250K | Buy |
1,984
+1
| +0.1% | +$124 | 0.01% | 451 |
|
|
2016
Q2 | $231K | Hold |
1,983
| – | – | 0.01% | 445 |
|
|
2016
Q1 | $206K | Hold |
1,983
| – | – | 0.01% | 469 |
|
|
2015
Q4 | $197K | Sell |
1,983
-391
| -16% | -$38.3K | ﹤0.01% | 452 |
|
|
2015
Q3 | $216K | Sell |
2,374
-470
| -17% | -$47.1K | 0.01% | 419 |
|
|
2015
Q2 | $303K | Hold |
2,844
| – | – | 0.01% | 388 |
|
|
2015
Q1 | $326K | Buy |
2,844
+122
| +4% | +$13.9K | 0.01% | 395 |
|
|
2014
Q4 | $299K | Sell |
2,722
-122
| -4% | -$12.9K | 0.01% | 406 |
|
|
2014
Q3 | $278K | Hold |
2,844
| – | – | 0.01% | 394 |
|
|
2014
Q2 | $285K | Hold |
2,844
| – | – | 0.01% | 362 |
|
|
2014
Q1 | $259K | Hold |
2,844
| – | – | 0.01% | 367 |
|
|
2013
Q4 | $256K | Sell |
2,844
-103
| -3% | -$8.91K | 0.01% | 355 |
|
|
2013
Q3 | $234K | Hold |
2,947
| – | – | 0.01% | 363 |
|
|
2013
Q2 | $213K | Buy |
+2,947
| New | +$220K | 0.01% | 365 |
|
Other funds holding ZBH
Synovus Financial's ZBH Position: Q3 2025 in Review
Synovus Financial increased its Zimmer Biomet (ZBH) stake by 7.9% in Q3 2025, buying an estimated $142K and bringing the position to 19,621 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #376.
Synovus Financial first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $7.3M in Q3 2023. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Synovus Financial held 19,621 shares of Zimmer Biomet worth $1.93M as of Q3 2025.
- Synovus Financial bought 1,430 Zimmer Biomet shares in Q3 2025, an estimated $142K.
- Zimmer Biomet made up 0.02% of Synovus Financial's portfolio in Q3 2025, its #376 holding.
- Synovus Financial first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
- Synovus Financial's Zimmer Biomet position peaked at $7.3M in Q3 2023.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.